The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units)

Novo Nordisk is set to introduce Awiqli, an innovative once-weekly insulin, in India shortly. This remarkable treatment drastically cuts down the number of insulin injections from…

Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients.…

The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units)

The injection replaces the need for a daily basal insulin injection with a once-a-week dose. This reduces the annual number of injections from 365 to just 52. | India News

Novo Nordisk launches Awiqli, the world's first once-weekly insulin, in India to revolutionize diabetes management.

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side effects, and dosage. | Health

India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 to just 52 for many individuals. Experts suggest…